Adaptimmune Therapeutics (STU:473A) Cash From Discontinued Investing Activities : €0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Adaptimmune Therapeutics Cash From Discontinued Investing Activities?

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Adaptimmune Therapeutics's cash from discontinued investing activities for the three months ended in Sep. 2024 was €0.0 Mil. It means Adaptimmune Therapeutics received €0.0 Mil from discontinued investing activities. Adaptimmune Therapeutics's cash from discontinued investing activities for the trailing twelve months (TTM) ended in Sep. 2024 was €0.0 Mil.

Adaptimmune Therapeutics Cash From Discontinued Investing Activities Historical Data

The historical data trend for Adaptimmune Therapeutics's Cash From Discontinued Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adaptimmune Therapeutics Cash From Discontinued Investing Activities Chart

Adaptimmune Therapeutics Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash From Discontinued Investing Activities

Get a 7-Day Free Trial

Adaptimmune Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash From Discontinued Investing Activities	Get a 7-Day Free Trial															-	-	-	-	-

Adaptimmune Therapeutics Cash From Discontinued Investing Activities Calculation

Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Cash From Discontinued Investing Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Adaptimmune Therapeutics Cash From Discontinued Investing Activities Related Terms

Thank you for viewing the detailed overview of Adaptimmune Therapeutics's Cash From Discontinued Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Adaptimmune Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adaptimmune Therapeutics PLC (STU:473A) » Definitions » Cash From Discontinued Investing Activities

Comparable Companies

Traded in Other Exchanges

ADAP:USA

Address

60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.adaptimmune.com

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing novel cell therapies to patients, particularly in solid tumors. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70 and others for multiple cancer types.

Adaptimmune Therapeutics Headlines

No Headlines